Importantly, we confirmed through mechanistic studies that ALDH3A1 is a direct transcriptional target gene of BMAL1, thus establishing a new molecular bridge between core circadian regulation and reprogramming of tumor glucose metabolism. This evidence concerns the gene BMAL1 and neoplasm.